Novo Nordisk A/S ADR buy melinda
Start price
17.01.17
/
50%
€32.79
Target price
24.04.17
€33.37
Performance (%)
2.29%
End price
24.04.17
€32.94
Summary
This prediction ended on 24.04.17 with a price of €32.94. With a performance of 2.29%, the BUY prediction by melinda for Novo Nordisk A/S ADR closed with a slight gain. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Novo Nordisk A/S ADR | 4.453% | 4.453% | -12.245% | 93.694% |
| iShares Core DAX® | -1.042% | 2.220% | 14.279% | 15.463% |
| iShares Nasdaq 100 | -1.361% | 3.207% | 26.657% | 53.266% |
| iShares Nikkei 225® | -0.044% | -1.680% | 5.941% | 4.271% |
| iShares S&P 500 | -0.480% | 2.165% | 23.067% | 45.283% |
Comments by melinda for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk (NVO) erhält FDA Orphan-Drug-Status von Diabetes Combo
folgen
Stopped prediction by melinda for Novo Nordisk A/S ADR
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€158.50
14.05.23
14.05.23
€165.00
14.05.24
14.05.24
-22.71%
15.05.24
15.05.24
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€43.06
01.09.17
01.09.17
€49.61
29.12.17
29.12.17
13.28%
29.12.17
29.12.17
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€47.74
01.09.17
01.09.17
€55.00
29.12.17
29.12.17
13.28%
29.12.17
29.12.17
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€37.95
06.07.17
06.07.17
€45.10
29.08.17
29.08.17
11.71%
29.08.17
29.08.17
Novo Nordisk A/S ADR
Start price
Target price
Perf. (%)
€42.07
06.07.17
06.07.17
€50.00
29.08.17
29.08.17
11.71%
29.08.17
29.08.17